Nerea Zabaleta, PhD, is an Instructor at Harvard Medical School. Her research lab forms part of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear Infirmary in Boston, USA, and of the Ocular Genomics Institute. She received a PhD degree in biomedical research from the University of Navarra, Spain, in 2018. She has a strong background in translational gene editing and gene therapy for inherited liver metabolic disorders as well as preclinical development of vaccines. Her laboratory aims at developing and optimizing adeno-associated viral vector (AAV)-based therapies for inherited and infectious disorders. Her goal is to create custom AAV vectors that adequate to the needs of each disease and target specific cell types rather than specific organs, creating more effective and safer therapies. Her work has been published in high impact journals, and she is inventor of two patents, including an AAV-based vaccine platform. Additionally, she is a board member of ECUSA (Spanish Scientist in the USA, non-profit) and volunteers her time to advocating for inclusion and gender equity.
This speaker appears at this event:
Nerea Zabaleta, PhD
Principal Investigator, Grousbeck Gene Therapy Center, Mass Eye and Ear
Instructor in Ophthalmology, HMS